Conservation of minor Histocompatibility antigens between human and non-human primates. by Goulmy, E.A.J.M.
2680 J Μ Μ den Hdan et al hui I Immunol 1996 26 2680 2681
Joke Μ. Μ. den Haan1,
Ronald E. Bontrop2,
Jos Pool1,
Nicholas Sherman3,
Eis Blokland1,
Victor H. Engelhard4,
Donald F. Hunt5 and
Eis Goulmy1
1
 Department of
Immunohaematology and
Bloodbank, Leiden Umversity
Hospital, Leiden, The Netherlands
1
 Department of Immunobiology,
Biomedical Primate Research
Centre, Rijswijk, The Netherlands
1
 Department of Chemistry,
Umversity of Virginia,
Charlottesville, USA
4
 Department of Microbiology and
Beirne Carter Center for
Immunology Research, Umversity
of Virginia, Charlottesville, USA
Departments of Chemistiy and
Pathology, Umversity of Virginia,
Charlottesville, USA
Conservation of minor histocompatibility antigens
between human and non-human primates
It is well aeeepted that rninor histocompatibility antigens (mHag) can function as
transplantation barners between HLA-matched mdividuals Little is known
about the molecular natuie and evolutionary conservation of mHag It is only
very recently that the first human mHag were identified The HLA-A2 1-
restneted mHag HA-2 and the HLA-B7-restncted mHag H-Y appeared to be
peptides denved from polymorphic seif proteins Here we show that the HLA-
A2 1-restncted mHag HA-1, HA-2, and the H-Y peptides are conserved
between man, chimpanzees and rhesus macaques Human cytotoxicTcell clones
specific for the HLA-A2 1-restncted mHag HA-1, HA-2, and H-Y recogmzed
HLA-A2 1 gene-transfected chimpanzee and rhesus macaque cells High-
pressure liquid chromatography fractionation of HLA-A2 1-bound peptides ISO-
lated from the HLA-A2 1-transfected chimpanzee cells revealed that the chim-
panzee HA-1 and HA-2 co-eluted with the human HA-1 and HA-2 Subsequent
amino acid sequencing showed that the chimpanzee HA-2 peptide is identical to
the human HA-2 peptide Our functional and biochemical results demonstrate
that mHag peptides are conserved for over 35 milhon years
1 Introduction
Dispanty for minor histocompatibility antigens (mHag)
between HLA-identical mdividuals can lead to graft-
versus-host disease (GVHD) after bone marrow trans
plantation [1] MHag-specific HLA-iestncted Tccll clones
can be generated ot PBMC hom patients suffenng trom
GVHD [2 3] UsingTcell clones specific for mHag HA-1
HA-2, HA-4, and HA-5, we showed that these non-sex
hnked mHag segiegate as Mendehan tiaits and mdepen
denlly from each other Each can be considered as the
pioduct of a gene with two alleles [4] Population gcnetic
studies revealed that HA 1 and HA-2 appeared frequently
(69 % and 95 % ) , whereas HA-4 and HA-5 oecurred with
lower frequencies (16% and 8%) in the healthy popula-
tion [5] Recently, the fnst two human mHdg have been
identified by amino acid sequencing of the HLA-bound
peptides that were recogmzed by the mHag specific Τ cell
clones The non-sex-hnked HLA-A2 1-restncted mHag
HA-2 most probably onginates hom a member of the
class I myosin protein family [6] and the male-specific
HLA-B7 lestncted mHag Η Υ is denved from the Υ
chiomosome-encoded SMCY (selected mouse cDNA on
the Y) piotein [7] The SMCY gene was shown to be con
[I 16082]
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served in evolution [8] Howevei until now no lnioima-
tion existed on the evolutionary conseivation of human
non-sex hnked mHag In the present study we investig
ated whether the human non-sex-hnked HLA-A2 1
lestncted mHag HA-1, HA-2, and HA-4 and the male-
specific HLA-A2 1-restncted mHag Η Υ are evolutionarv
conseived Foi this functional studies biochemical pun
fication and amino acid sequence analyses were per
formed We transfected chimpanzee and rhesus macaque
Β cell hnes with the HLA-A2 1 restnction molecule and
used these cells as target cells loi recognition by the HLA-
A2 1 lestncted mHag-specific CTL clones Subsequentlv
the mHag HA-1 and HA-2 peptide were eluted from the
tiansfected HLA-A2 1 chimpanzee cells and showed simi-
lai HPLC elution patterns when compared with human
HA 1 and HA-2 peptides Sequence analysis of chimpan-
zee HA-2 levealed an amino acid sequence identical to the
human HA-2
2 Materials and methods
2.1 Transfection and cell eulture
Chimpanzee Β cell hnes were generated from six unrelated
chimpanzees dcnved from the Biomedical Primate
Research Centre colony Theo (chimpanzee, 1, c?), Pearl
(chimpanzee 2, 9), Debbie (chimpanzee 3, 9), Brigitte
(chimpanzee 4, 9), Sheny (chimpanzee 5, 9), Japie
(chimpanzee 6, ό) Two ihesus macaque Β cell hnes weie
generated from 2849 (rhesus macaque 1, 9) and IWM
(ihesus macaque 2, <$), both denved from the Biomedical
Primate Research Centre colony The cells were main-
tamed in RPMI 1640 medium containing 10% tetal calf
serum and 3 mM ) -glutamine Rhesus macaque cell hnes
were eultuied in the presence of 0 6 μg/ml 3'-azido-3'-
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deoxythymidinc Cells were transfected with pHEBO A2 1
by electroporation usmg a Bio-Rad Gene Pulser Cells
were routinely shocked at 960 μΡ, 210 V in the presence of
62 5 μ&τηΐ uncut plasmid DNA Cuvettes of 0 4 cm were
used, with about 12 χ 106 cells in 0 8 ml phosphate-buf-
fered sahne Transfected cell hnes were maintained in the
presence of 125-250 μg/ml hygromycin [9] The HLA-
A2 1-allospecific CTL clones 3E7 and 3E5, the HLA-
A2 1-restncted HA-1-specihc CTL clone 3HA15, the
HLA-A2 1-restncted HA-2-specific CTL clone 5H13, the
HLA-A2 1-restncted HA-4-specific CTL clones 5G30 and
5Gy8, and the HLA-A2 1-restncted H-Y-specific CTL
clone 1R35 were cultured by weekly Stimulation with
irradiated allogeneic PBMC and B-lymphoblastoid cell
hne (BLCL) cells in RPMI 1640 medium contaming 15 %
human serum, 3 mM L-glumtaine, 1 % leukoagglutinin Α
and 20 U/ml recombinant IL-2 [5]
2.2 51Cr-reIease assay
"Cr-labeled target cells (5000) were incubated together
with different numbers of HLA-A2 1-allospecific and
mHag-specific CTL clones in 200 μΐ MCr lelease was
determined after 4 h at 37 °C The percent speeihe lysis
was calculated as follows percent specific lysis = [(expen-
mental release - spontaneous release)/(maximal relea-
se - spontaneous release] x 100 Spontaneous release
and the maximal release were the s lCr release of the target
cells in eulture medium alone and in eulture medium con-
tainzng 1 % Triton X-100, respectively
2.3 Peptide purißcation
Peptides were eluted out of punfied HLA-A2 1 molecules
as desenbed [6, 10] Bnefly, HLA-A2 1 molecules were
punfied from 2 05 x 10K) transfected chimpanzee cells by
affinity chromatography with BB7 2-coupled CNBr
activated Sepharose 4B beads (Pharmacia LKB, Uppsala
Sweden) Peptides were eluted from the HLA-A2 1 mole-
cules by acid treatment and separated from the HLA A2 1
heavy chain and ß2-microglobuhn by filtration over a 10-
kDa-cutoff Centncon (Amicon, Lexington, MA) filter
Peptides were fractionated using reverse-phase micro
HPLC (Smart System, Pharmacia) Buffer Α was 0 1 %
tnfluoroacetic acid (TFA), bufter Β was 0 1 % TFA in ace-
tonitnle The gradient consisted of 100% buffer Α (0 tu
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Figure 1 HLA-A2 1-transfected chimpanzee celi hnes are lysed by HLA-A2 1-allospecific and by HLA-A2 1-reslntted HA 1, HA 2
and H-Y-specinc CTL clones (A) Lysis by the HLA A2 l-allospetific CTL clone, (B) lysis by tht HLA-A2 1-restncted HA-1-specific
CTL clone, (C) lysis by the HLA-A2 1 restneted HA-2 specific CTL clone, (D) lysis by the HLA-A2 1-restncted HA-4-speciiic CTL
clone, and (E) lysis by the HLA-A2 1 restneted H-Y-specitic CTL clont Solid hnes represent the HLA-A2 1 transfected cell hnes, and
dotted hnes represent the nontranslected cell hnes All Ε/Γ ratios lested were 20 1 and 2 1 except for chimpanzee 6 For both the
HLA A2 1 transfected and the nontransfected chimpan/ee 6 cell hne, E/T ratios of 13 1 and 1 3 1 were used for the HLA A2 1
allospecific CTL, E/T ratios of 5 1 and 0 5 1 werc used for the HA-4-specific CTL and E/T ratios of 11 1 and 1 1 1 were used tor the
HLA A2 1 restneted Η-Υ CTL
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20 min), 0 to 12 % buffer Β (20 to 25 min), and 12 to 50 %
buffer Β (25 to 80 min) at a flow rate of 100 μΐ/min. Frac-
tions of 100 μ] were collected. In the MCr-release assay,
2.5 μΐ of each fraction was diluted in 25 μΐ HBSS buffered
with 50 mM Hepes. MCr-labeled T2 cells (2500) were
ineubated with the fractions in 50 μΐ for 30 min at 37 °C.
HA-2-specific Τ cells were added for an E/T ratio of 17:1
in final volume of 150 μΐ for 4 h at 37 °C.
2.4 Mass spectrometry
Collision-activated dissociation spectra were recorded on a
tnple-quadrupole mass spectrometer (Finnigan-MAT, San
Jose, CA) operating with a two mass-unit window in quad-
rupole 1.
transfected with the HLA-A2.1 gene and analyzed with
HLA-A2.1-restncted mHag-specific CTL clones in a 51Cr-
release assay (Figs. 1, 2). All transfected cell lines were
recognized by the HLA-A2.1-allospecific CTL clone (Figs.
ΙΑ, 2Α). Differences in lysis by the HLA-A2.1-allospecific
CTL clone was correlated with differences in HLA-A2.1
expression as determined by FACS analysis (data not
shown). The HA-1- and HA-2-specific CTL clones lysed
all six chimpanzee and two rhesus macaque cell lines,
whereas no HA-4 reactivity could be detected
(Figs. 1B-D; 2B-D). All HLA-A2.1-transfected male
chimpanzee and rhesus macaque cell lines were recognized
by the HLA-A2.1-restncted H-Y-specific CTL clone
(Figs. 1E, 2E). These results demonstrate that the HA-1,
HA-2, and Η-Υ Τ cell epitopes are functionally expressed
on these cells.
3 Results
3.1 Recognition of HLA-A2.1-transfected chimpanzee
and rhesus macaque Β cell lines by human mHag-
specific CTL clones
Six unrelated chimpanzee (Pari troglodytes) and two unre-
lated rhesus macaque (Macaca mulatta) Β cell lines were
3.2 Chimpanzee HA-1 and HA-2 peptides have similar
HPLC retention times as human HA-1 and HA-2
To test the assumpüon that the endogenously processed
mHag HA-1 and HA-2 peptides in non-human primates
are identical to the human HA-1 and HA-2, HLA-A2.1-
bound peptides were isolated from an HLA-A2 1-
tiansfected chimpanzee cell hne as described [6, 10]. After
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Figure 2 HLA-A2 1-transfected rhesus macaque cell lines are lysed by HLA-A2.1-allospecific and by HLA-A2.1-restncted HA-1, HA-
2, and H-Y-specific CTL clones (A) Lysis by the HLA-A2 1-allospecific CTL clone, (B) lysis by the HLA-A2.1-restncted HA-1-
specific CTL clone, (C) lysis by the HLA-A2 1-restncted HA-2-specific CTL clone, (D) lysis by the HLA-A2 1-restncted HA-4-specific
CTL clone, and (E) lysis by the HLA-A2 1-restncted H-Y-specific CTL clone Solid hnes represent the HLA-A2.1-transfected cell lines
and dotted lines represent the nontransfected cell lines E/Tratios (A) in (B) weic 10:1 and 1:1 tor the transfected as well as the non-
translected rhesus macaque 1 cell hne tor all CTL clones except for the HA- 1-specific CTL clone, where E/T ratlos of 30:1 and 3 · 1 were
used. For both the transtected as the nontransfected rhesus macaque 2 cell hne, E/T ratio Α was between 7 1 and 20.1 and ratio Β was
betwecn 0 7 1 and 2 1 for the different CTL clones
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Figure 3 (Α) Activity of HPLC fractions of
HLA A2 1 eluted chimpanzec peptides in a
MCr release assay using HA 1 and HA 2
specific CTL clones as effector cclls comparcd
with the HPLC elution profile of a rcference
peptide (B) Activity of HPLC fractions of
HLA A2 1 eluted human peptides in a Cr
release assay using HA 1 and HA 2 specific
CTL clones as effector cells and compared with
the HPLC elution profile of a refcrence pep
tide For both HA-1 (open circles) and HA 2
(closed circles), one peak of activity was found
in the chimpanzee and the human HLA A2 1
eluted peptides Both the chimpanzee and
human HA 2 active fractions were found at the
same position when compared with the elution
profile of the reference peptide (solid lint) The
human and chimpanzee HA 1 active fractions
eluted six and seven fractions earher when com
pared with the HA 2 active fractions Ihis shilt
of one fraction of HA 1 IS within the norm il
ränge of Variation between HPLC runs
HPLC fractionation, the chimpanzee peptide fractions
were assayed with the mHag HA-1 and HA 2 specific CTL
clones For both HA-1 and HA-2 that were eluted from
the transfected chimpanzee cells, one peak ol activity was
found (Fig 3A) which was also observed for human HLA
A2 1 eluted peptides (Fig 3B) When the positions of the
HA 1 and HA-2 active fractions were compared to the elu
tion profile of a reference peptide that was run lmmedi-
ately before the eluted peptides, both the chimpanzee
HA-1 and HA-2 active fractions eluted approximately at
the same position as the human HA 1 and HA 2 active
fractions This suggests that the chimpanzee HA 1 and
HA-2 peptides have similar biochemical properties as the
human HA-1 and HA-2 peptides
3.3 The chimpanzee and human mHag HA-2 peptide
sequence is identicai
Recently, we identified the human mHag HA 2 as
YIGEVLVSV with a mass-to-charge ratio of m/z 978 [6]
Collision-activated dissociation (CAD) analysis by tandem
mass spectrometry of m/z 978 in the chimpanzee HA-2
positive fraction revealed the sequence YXGEVXVSV
(Fig 4A), which is identicai to the human HA-2 amino
acid sequence (Fig 4B) Smce the mass spectrometer we
used cannot differentiate between Leu and Ile (repre-
sented by X), it remains to be established whether positi-
ons 2 and 6 encode Leu or Ile, which is also true for the
human mHag HA-2 [6]
4 Discussion
Humans, chimpanzees and rhesus macaques share a com-
mon ancestor that lived 35 milhon years ago [11] The
divergence between man and chimpanzees took place
around 5 milhon years ago [12] The functional recognition
of the HLA-A2 1 transfected chimpanzee and rhesus
macaque cells by the H-Y, HA 1 and HA-2-specific CTL
and the biochemical peptide charactenzation of the non
human pnmate mHag clearly demonstrate that human
mHag peptides are conserved for at least 35 milhon \ tais
of pnmate evolution Thus the mHag proteins leadin» to
these mHag peptides are of functional importance Moic
over the mHag peptide identity shows that the proccssin»
and presentation machinery in respect to mHag is ton
seived as well This underlines earher suggestions that the
processing and presentation machinery may be conscrvcd
between species in general It has been shown that Η 2Κ
transfected human cells could present allopeptides to
mouse Η 2Kh restneted CTL [13] Furthermore lysis was
observed of H-2Kd/vaccinia virus-transfected rat Svnan
hamster, monkey and human cells by mouse H 2 K 1
restneted vaccinia specific CTL [14]
Information on conservation of mHag is scarce except for
the mHag H-Y Recently, both a human HLA B7-
restneted H-Y antigen and a mouse Kk-restncted H-Y
antigen were shown to be denved from the Υ chromosome
encoded SMCY protein [7, 15] This protein is evolutio
nanly conserved and expressed in both humans and miee
although the H-Y Tcell epitopes are not Conservation of
an HLA-B27-restncted H-Y antigen has been desenbed in
HLA-B27-transgemc mice and rats, however, human cells
were not recognized by the rat H-Y-specific HLA B27
restneted CTL [16] Although it remains to be established
whether other H-Y mHag, hke the HLA-A2 1 restneted
H-Y Τ cell epitope, are also encoded by the SMCY genc,
we show here that the HLA-A2 1-restneted H-Y peptide
is also conserved in evolution
Die phenotype frequencies of mHag HA-1, HA 2, and
HA-4 in the HLA-A2 1+ Caucasian population are 69%
95 %, and 16 %, respectively [5] All the chimpanzee and
rhesus macaque HLA-A2 1-transfected cell hnes analyzed
in this study expressed HA-1 and HA-2, whereas none
expressed HA 4 These results suggest that different phe
notype frequencies may exist for the mHag in non-human
pnmates Alternatively, the polymorphisms of the HA 1,
HA 2, and the HA 4 loci may have a nsen after the diver
gence between chimpanzee and man However, the num
ber of chimpanzee and rhesus macaque cell lmes analyzed
in this study is too low to draw any conclusions
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Figure 4 Colhsion actwated dissociation mass
spectrum of mHag HA 2 (M + H)J' 10ns with
m/z 978 The predicted mass foi fragment 10ns
of type b and y are shown, respectively above
and below the deduced amino acid sequence
Ions obscrved in the spectrum aie underlmcd
Lxx leprescnts Ile or Leu which have identical
masscs and cannot be differentiated in this mass
spectiometer (A) Spectium of peptide
YXGEVXVSV obtained from chimpanzee
cells (B) Spectium of peptide YXGEVXVSV
obtained from human cells
This study IS the first demonstration of evolutionary con-
seivation of non-sex-lmked human mHag On the one
hand, the identity of human and chimpanzee mHag may
have implications for xenotransplantation Xenotrans-
plantation of non-human pnmate tissue can lead to Τ cell
responses to mHag peptides presrnted via the indirect
pathway On the other hand, our results show the possibil-
lty to use non-human pnmates a» a model to study bone
marrow transplantation-related ieactivities such as GVHD
and graft-versus-leukemia reartions
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